Phase 2 Liver Cancer Trial, Recruiting (NCT05304234)

Phase 2 Liver Cancer Trial, Recruiting NCT05304234 Sponsor: University of Washington Condition: Liver Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT05304234 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Liver Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have cirrhosis (scarring of the liver) from any cause, or you have a long-term hepatitis B infection
You are considered at high risk of developing liver cancer (hepatocellular carcinoma)
You are between 18 and 75 years old
You are able to understand and agree to participate by signing a consent form

Who may not be able to join:

You have already been diagnosed with liver cancer
Doctors currently suspect you may have liver cancer
You have previously received an organ transplant
You are already taking part in another liver cancer screening study
Your liver disease is at a severe stage, based on a scoring system called the Child-Turcotte-Pugh (CTP) score of 10 or above (confirm with trial site)
Your liver disease score on another measure called MELD-Na is above 20 (confirm with trial site)
Your kidneys are not working well enough, based on a measure called GFR being below 30 (confirm with trial site)
Your general health means you are not expected to live for 5 or more years
You have a reason why you cannot safely have an MRI scan
You are unable to attend the required study visits
You are currently pregnant

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 27 July 2026

Phase 2: approximately ~30% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.

Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

Contact this trial

Principal Investigator: George Ioannou, MD, MS, University of Washington

Phone: 206-616-0397

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05304234

Sponsor: University of Washington

Phase: Phase 2

Status: Recruiting

Condition: Liver Cancer

Trial contact: 206-616-0397

More information: https://clinicaltrials.gov/study/NCT05304234

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have cirrhosis (scarring of the liver) from any cause, or you have a long-term hepatitis B infection
You are considered at high risk of developing liver cancer (hepatocellular carcinoma)
You are between 18 and 75 years old
You are able to understand and agree to participate by signing a consent form

Who may not be able to join:

You have already been diagnosed with liver cancer
Doctors currently suspect you may have liver cancer
You have previously received an organ transplant
You are already taking part in another liver cancer screening study
Your liver disease is at a severe stage, based on a scoring system called the Child-Turcotte-Pugh (CTP) score of 10 or above (confirm with trial site)
Your liver disease score on another measure called MELD-Na is above 20 (confirm with trial site)
Your kidneys are not working well enough, based on a measure called GFR being below 30 (confirm with trial site)
Your general health means you are not expected to live for 5 or more years
You have a reason why you cannot safely have an MRI scan
You are unable to attend the required study visits
You are currently pregnant

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 27 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Phase 2

Sponsor

University of Washington

Registry

ClinicalTrials.gov

Start date

1 April 2022

Est. completion

1 September 2025

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Compliance with screening protocol; Feasibility of screening protocol

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov